Insights on the Global Pharmaceutical Contract Research And Manufacturing Market 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats - Technavio
The pharmaceutical contract research and manufacturing market is expected to grow by $ 69.09 bn, progressing at a CAGR of over 9% during the forecast period.
Pharmaceutical Contract Research And Manufacturing Market: Service Landscape
Based on the service, the CMO segment is expected to witness lucrative growth during the forecast period.
Pharmaceutical Contract Research And Manufacturing Market: Geographic Landscape
By geography, North America is going to have a lucrative growth during the forecast period. About 36% of the market's overall growth is expected to originate from North America. The US is the key market for pharmaceutical contract research and manufacturing in North America.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The point of care diagnostics market size has the potential to grow by USD 10.69 billion during 2020-2024. However, the market's growth momentum will decelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
Prostate Biopsy Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The prostate biopsy market size has the potential to grow by USD 380.23 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
Companies Covered:
Boehringer Ingelheim International GmbH
Cadila Healthcare Ltd.
Catalent Inc.
Dr. Reddy's Laboratories Ltd.
ICON Plc
IQVIA Holding Inc.
Laboratory Corporation of America Holdings
Lonza Group Ltd.
PRA Health Sciences Inc.
and Thermo Fisher Scientific Inc.
What our reports offer:
Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers market data for 2019, 2020, until 2024
Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
North America - Market size and forecast 2019-2024
APAC - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Drivers, Challenges, and Trends
Market drivers
Volume driver - Demand led growth
Volume driver - Supply led growth
Volume driver - External factors
Volume driver - Demand shift in adjacent markets
Price driver - Inflation
Price driver - Shift from lower to higher-priced units
Market challenges
Market trends
Vendor Landscape
Overview
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
Boehringer Ingelheim International GmbH
Cadila Healthcare Ltd.
Catalent Inc.
Dr. Reddy's Laboratories Ltd.
ICON Plc
IQVIA Holding Inc.
Laboratory Corporation of America Holdings
Lonza Group Ltd.
PRA Health Sciences Inc.
Thermo Fisher Scientific Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024.
Highlights for the Quarter:
Net income available to common...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...